Start New Topic

anti-FBP CAR-T in vivo assay

Folate-binding protein (FBP) is over-expressed in more than 90% of ovarian and endometrial cancers as well as 20-50% of breast, lung, colorectal, and renal cell carcinomas. It has very limited distribution in normal tissues, which makes it a potential immunotherapy target and also a marker for ovarian cancer. Learn more: anti-FBP CAR-T in vivo assay

Posted on : Mon, Sep 23, 2024 1:57 AM
Posted By : Catalina Garcia

0 Replies:

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News